Verition Fund Management
ICPT

Verition Fund Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Verition Fund Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,600
Closed -$322K – 1139
2019
Q4 		$322K Buy
+2,600
New +$233K 0.01% 806
2018
Q4 		– Sell
-11,900
Closed -$1.5M – 1354
2018
Q3 		$1.5M Buy
11,900
+2,500
+27% +$265K 0.05% 413
2018
Q2 		$789K Buy
+9,400
New +$688K 0.05% 511

Verition Fund Management's ICPT Position: Q4 2023 in Review

Verition Fund Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 11,439 shares — an estimated $212K sold.

Verition Fund Management first reported a position in ICPT in Q3 2014 and held it in 11 quarters. The position peaked at $599K in Q3 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Verition Fund Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 11,439 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $212K.
  • Verition Fund Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 11 quarters.
  • Verition Fund Management's Intercept Pharmaceuticals, Inc. position peaked at $599K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.